Jorge L. Alio MD PhD Ma. Cecilia C. Agdeppa MD VISSUM-Instituto Oftalmologico de Alicante ASCRS...
-
Upload
reginald-baldwin -
Category
Documents
-
view
213 -
download
0
Transcript of Jorge L. Alio MD PhD Ma. Cecilia C. Agdeppa MD VISSUM-Instituto Oftalmologico de Alicante ASCRS...
Jorge L. Alio MD PhD Ma. Cecilia C. Agdeppa MDVISSUM-Instituto Oftalmologico de AlicanteASCRS Convention 2010 Boston
Efficiency of MicroIncision Cataract Surgery using comprehensive MICS
in Different Cataract Densities
Financial DisclosureProf. Jorge L. Alió MD, PhD.
D AcuFocus A-D Akkolens D Alcon Laboratories A-D Bausch&Lomb D Carl Zeiss Meditec D Chemedica A Eyemaginations P Index Instruments D IntraLase Corporation
A MediphacosD Novagali PharmaD-P NulensA Ocular Surgery News/SlacA-D OculentisA PresbiaD-E Schwind eye-tech-solutionP Springer VerlagP TekiaD Thea
Introduction
Rapid evolution of cataract surgery due to development of newer, better, more sophisticated technologies and surgical techniques
Leading the forefront is MICS and phaco systems best suited for microincision surgeries such as the Stellaris Vision Enhancement system
Purpose of the Study
To evaluate the efficiency of microincision cataract surgery (MICS) using the Stellaris Vision Enhancement System in different cataract densities
Study Design and Patients
Non Randomized Descriptive Study 109 eyes of 65 patients All patients underwent MICS using
the Bausch&Lomb Stellaris Phacoemulsification System
Visually significant based on the LOCS scale
Inclusion and Exclusion Criteria
Inclusion Criteria age 40 years to 90 years no history of ocular surgery non-diseased cornea and normal fundus
examination Exclusion Criteria
eyes with more than 3.00 diopters (D) of astigmatism
previous corneal and refractive surgeries those who had history of ocular disease
MICS Steps A dominant incision was made in the positive meridian of the astigmatism
approximately 1.2mm wide internally and 1.4mm externally A sideport incision using the same knife was placed 90o to 110o from the
main incision. Anesthesia was achieved by injecting 1% lidocaine into the anterior chamber. Pupillary dilation was obtained with intracameral mydriatics using
phenylephrine 10.0% and tropicamide 10%. A dispersive ophthalmic viscosurgical device (OVD) was instilled to fill the
anterior chamber Capsulorrhexis of approximately 5.5mm was made using the 23-gauge Alió
MICS Capsulorrhexis Forceps (Katena, Inc) Adequate hydrodissection was done Prechopping was done. Phacoemulsification was achieved using the Stellaris Vision Enhancement
System (Bausch & Lomb).
Stellaris Phacoemulsification System Improvement and innovation in
phacoemulsification technology Advanced Flow Module (EQ Fluidics)
Enhanced followability and aspiration control Minimum post-occlusion surge Rapid return to solid state
Stable Chamber Pack Micro-mesh filter system with reduced
diameter tubing Provides greater holding power at low flow
rates even at higher vacuum levels
Stellaris Phacoemulsification System Custom Control Software II
Permits millisecond range modulation ultrasound control
Variable duty cycle application of 28.5kHz ultrasound for optimized cavitation and rapid emulsification
Ergonomic Design New six-crystal ergonomic handpiece for
optimized cutting and cavitation Bluetooth wireless dual linear foot pedal
Results
Patient Characteristics 109 eyes of 65 patients 42 (65%) females, 23 (35%) males Mean Age 69 years (range 40-93 years)
Results
Results
Mean Vacuum
Phaco Power (%)
APT1 EPT2
LOCS I 381.82±29.93
0.36% 0.0062±0.0077
0
LOCS II 361.2±61.86
1.08% 0.16±0.14 0.003±0.002
LOCS III 356.46±64.65
1.5% 0.30±0.25 0.0071±0.0064
LOCS IV 365.79±66.78
2.21% 0.96±0.81 0.021±0.02
LOCS V 391.67±20.41
3.5% 2.36±1.56 0.067±0.041 APT: Average Phaco Time2 EPT: Effective Phaco Time
Burst Duration: 20 pulses per secondDuty Cycle: 60%
Conclusion
MICS with the Stellaris Vision Enhancement System is possible in all cataract densities with minimal use of phaco power (max 3.5% for grade 5 cataract) and very low phacoemulsification time allowing excellent efficiency of the surgery as manifested by the low EPT found in all cataract groups.